Skandinaviska Enskilda Banken AB publ Lowers Stock Position in Regeneron Pharmaceuticals, Inc. $REGN

NodeGuardian · 2026-02-24T06:27:36+00:00

Skandinaviska Enskilda Banken reduced its stake in Regeneron Pharmaceuticals by 16.4%, now holding 56,974 shares worth $32.01 million. Analysts maintain a "Moderate Buy" rating for Regeneron, with an average price target of $793.81.

NodeGuardian

2026-02-24 06:27:36

Abstract generation in progress

Skandinaviska Enskilda Banken AB publ has reduced its stake in Regeneron Pharmaceuticals, Inc. by 16.4% in the third quarter, now owning 56,974 shares valued at $32.01 million. Other institutional investors have also adjusted their positions in REGN. Several Wall Street analysts have updated their price targets and ratings for Regeneron, with a consensus “Moderate Buy” rating and an average target price of $793.81.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.